Eligard 30 mg (Leuprolide Acetate POWDER FOR SUSPENSION, SUSTAINED-RELEASE) 30 MG

Eligard 30 mg is a sustained-release powder for suspension used for hormone-related conditions. This subcutaneous injection contains leuprolide acetate and is manufactured by Tolmar International Ltd. in Ireland.

Strength

30 MG

Pack Size

0.5ML

Manufacturer / TM Owner

TOLMAR INTERNATIONAL LTD.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Eligard 30 mg is primarily used for conditions requiring hormone regulation, such as prostate cancer. This medication works by reducing the production of certain hormones in the body. It is often prescribed for long-term management of specific health issues related to hormone levels.

Side Effects

Common effects of Eligard 30 mg may include temporary discomfort at the injection site, hot flashes, and changes in bone density. Some users may experience fatigue or mood changes. These effects vary and are not exhaustive; individual responses can differ.

Precautions & Warnings

Eligard 30 mg should be handled with care, ensuring proper storage and administration by a healthcare professional. It is important to discuss any existing medical conditions or allergies with your healthcare provider before use. Follow all safety guidelines provided with the medication.

Avoid Interactions

Eligard 30 mg may interact with other medications, including those that affect hormone levels or blood clotting. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also interact with this medication.

Frequently Asked Questions

Eligard 30 mg is used for hormone-related conditions, such as prostate cancer, by reducing hormone production in the body.

Eligard 30 mg is administered as a subcutaneous injection, typically by a healthcare professional.

Common effects may include discomfort at the injection site, hot flashes, and changes in bone density.

Potential interactions with other medications should be discussed with a healthcare provider to ensure safety.

Precautions include proper storage, administration by a healthcare professional, and discussing existing medical conditions with your healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.